info iconCurrently, the share price for Divi's Laboratories Ltd. is delayed.

close icon
Divi's Laboratories Ltd. Logo

Divi's Laboratories Ltd.

--   ( -- %) 1D

  • Prev. Close
  • Upper Circuit
  • Lower Circuit

Analyst Recommendations For Divi's Laboratories Ltd.

Info icon
As recommended by 7 analysts


Divi's Laboratories Ltd.'s Info & Management

Founded in 1990, Divi’s Laboratories Limited is a prominent leader in the pharmaceutical industry. They hold a dominant position in the export market. It is based in Hyderabad, India.

Business Segment

The business operations include:

  • Primary Business Segment: manufacturing and sale of Active Pharmaceutical Ingredients, intermediates, custom pharmaceutical services, and nutraceutical ingredients
  • Product Portfolio: includes Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam and more

In addition to generic business, the company, through its custom synthesis business, supports pharma companies for their patented products business right from gram scale requirements for clinical trials to launch, as well as late life cycle management. 

Geographical Presence

The geographical reach spans Asia, America, Europe, and the rest of the world. The company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.

  • Executive Director,Whole Time Director,Chief Executive Officer
    Kiran S Divi
  • Chief Financial Officer
    Mr. L. Kishore Babu
  • Company Secretary,Compliance Officer
    Satish Choudhury

FAQs on Divi's Laboratories Ltd.

What is the share price of Divi's Laboratories Ltd.?

Divi's Laboratories Ltd. share price is ₹3,737.50 as of April 22, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Divi's Laboratories Ltd.?

The 52-week high and low of Divi's Laboratories Ltd. is ₹4,074.40 and ₹3,051.70 respectively as of April 22, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Divi's Laboratories Ltd.?

The trailing twelve month (TTM) PB ratio of Divi's Laboratories Ltd. is 7.60 as of April 23, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Divi's Laboratories Ltd.?

The Upper Circuit of Divi's Laboratories Ltd. is ₹4,039. The Lower Circuit of Divi's Laboratories Ltd. is ₹3,305.

What is the ROE of Divi's Laboratories Ltd.?

Divi's Laboratories Ltd. reported an ROE of 14.28% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Divi's Laboratories Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Divi's Laboratories Ltd., Promoter held 51.9%, the FII held 14.7%, DII held 22.2% and the public held 11.2% of the total shares.

How to buy Divi's Laboratories Ltd. Share?

You can easily buy shares of Divi's Laboratories Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Divi's Laboratories Ltd.?

The fair value of Divi's Laboratories Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer